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ETIOLOGY OF SCARLET FEVER* 
DR. A. R. DOCHEZ 
Professor of Medicine, College of Physicians and Surgeons, Columbia 
University, New York 
S CARLET FEVER is in all probability a very old disease.The regions in which the malady originally arose are a mat­
ter of uncertainty. There are some who believe that the Plague 
at Athens was a malignant form of scarlet fever, an interesting 
assumption in view of the present relatively low case fatality and 
the ominous variability in severity of outbreaks in the past. 
Fairly accurate descriptive records of scarlet fever appear in the 
literature as early as the middle of the sixteenth century and 
recur with increasing frequency and definiteness up to the time 
of Sydenham. For many years the disease was confused with 
measles, erysipelas, diphtheria and certain septic processes. 
Sydenham, who first employed the name scarlet fever, clearly 
differentiated it from measles by his careful description of the 
disease as it appeared in London from 1661 to 1675, and laid 
the foundation of an accurate knowledge of its special characters. 
In spite of this valuable contribution, the existing confusion did 
not disappear, and many physicians still confounded it with 
diphtheria and certain septic anginas. With the increasing 
volume of medicar literature and better facilities for the com­
munication of ideas, scarlet fever became mol'e and more clearly 
defined as a clinical entity. Confusion, however, with diphtheria 
frequently occurred, even down to the times of accurate diag­
nosis by means of bacteriological methods. In fact, even today 
the inability to differentiate scarlet fever from certain septic 
conditions of the throat, associated with erythematous rashes, 
continue� to plague the mind of the diagnostician. In spite of 
these diagnostic difficulties clinical differentiation of scarlet fever 
from other e:x:anthemata has been possible for a long �ough 
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period of time to determine clearly its contagious nature and to 
permit illuminating epidemiological and clinical studies. 
The contagious element in scarlet fever is probably always 
derived from a previous case. In most instances it is taken 
directly into the mouth or nasopharynx by the inhalation of air 
charged with minute droplets of saliva or mucous projected from 
the mouth or nose of the infected individual. Other important 
sources of contagion are the purulent discharges from infected 
paranasal sinuses, from suppurative inflammation of the middle 
ear and lymph glands, secondary conditions that constitute the 
most frequent and distressing complications of the disease. 
There is much evidence to support the view that the causative 
organism survives in the dry state in a virulent form for long 
periods of time. Contamination, therefore, of clothing or per­
sonal articles of any kind with infective matter may serve as a 
means of conveying scarlet fever. Formerly the belief was 
quite prevalent that flakes of skin given off during the period 
of desquamation were ·the most important vehicle of the con­
tagion, and quarantine regulations were roughly founded on 
time periods corresponding with the duration of the desquama­
tive stage. Current opinion .holds that the contagious element is 
not present in the skin in the late stages of scarlet fever, a some­
what curious fact, inasmuch as the rash is the most distinctive 
clinical manifestation of the disease. The role of the healthy 
carrier in spreading scarlatina is undoubtedly ·of great impor­
tance but determined accurately as yet in only a very few 
instances because of the uncertainty concerning the etiological 
agent.- That such types of carriers do exist there can be no 
doubt, and Bliss 1 has been able . to. trace a small epidemic of 
scarlet fever to such a source. Another interesting means of the 
wide dissemination of scarlet fever is an infected milk supply 
and numerous undoubted outbreaks have arisen from the con­
sumption of contaminated milk. The clinical and epidemiologi­
cal evidence, therefore, that has been collected indicates that the 
causative agent of s_carlet fever is present in the throat secretions 
and the discharges from suppurative foci in patients throughout 
the illness, and for a considerable period of time during con-
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valescence. It resists -exposure to light, and in the dry state may 
retain its infectivity for many months. Healthy carriers and 
atypical attacks of the disease are not an infrequent occurrence. 
In all probability the udder of the cow may become infected with 
the specific virus, and the milk obtained from this animal may 
serve as a vehicle of infection. 
Notwithstanding these excellent clinical and epidemiological 
studies which have ensured the easy recognition of typical 
attacks of the disease, and which have furnished the essential 
data for useful quarantine regulations, the causative organism 
of scarlet fever has remained unknown. Experimental studies 
have been published from time to time, suggesting that the infec­
tive agent belongs to one or other of the principal groups of 
microorganisms, such as the pathogenic bacteria, protozoa, and 
the so-called ultra.microscopic viruses. As a bacterial cause, 
Streptococcus hremolyticus has aroused much interest and stimu­
lated more or less continuous investigation because of its con­
stant association both with the uncomplicated and complicated 
forms of the disease. Certain observers have discovered inclusion 
bodies in leucocytes and in epidermal cells which they have 
thought indicative of a protozoan cause for scarlet fever. 
Finally, scientific opinion seized upon those mysterious living 
bodies commonly designated as filterable viruses as the most 
probable cause of the disease. This latter view has become most 
widely accepted and is the usual etiology assigned in text books 
in spite of the fact that no real evidence has ever been produced 
to show that any such microorganism exists either in the 
throat secretions, tissues or blood of an individual suffering 
from scarlatina. 
Both Mallory 2 and Dohi'e 3 have made the suggestion that 
scarlet fever may be due to a protozoan infection. In 1904 Mal­
lory observed in four cases of scarlet fever certain bodies whose 
varying morphology strongly suggested that they might have 
been stages in the development cycle of a protozoan. They 
occurred in and between the epithelial cells of the epidermis and 
free in the superficial lymph vessels and spaces of the. corium. 
They formed a series of bodies including definite rosettes, which 
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closely resembled those seen in the asexual development of the 
malarial parasite. There were also certain coarsely reticulated 
forms which he thought might represent stages in sporogony. 
Mallory was of the opinion personally that these bodies were 
protozoa and bore an etiological relationship to scarlet fever, but 
he did not regard their significance as established. Confirmatory 
observations were subsequently made by Duval/ Bernhardt G 
and v. Prowagek.0 Similar bodies, however, were later found by 
Field 7 in other conditions and they finally came to be looked 
upon as p.eculiar products of cell degeneration and not as living 
.forms with a specific relationship to scarlet fever. 
In 1912 Dohle,on examining the blood smearsfrom thirtycases 
of scarlet fever, found within the cytoplasm of the neutrophilic 
polynuclear leucocytes multiform inclusion bodies. These inclu­
sions were present in a large percentage of all leucocytes and by 
special methods of staining revealed themselves as intermediate 
in intensity between nucleus and cytoplasm. In a later communi­
cation certain of these inclusions are designated as '' Spirochrota 
scarlatin�,'' and are assigned both diaITTJ.ostic and prognostic 
importance. Although numerous observ:ers confirmed Dohle's 
observations on the presence of leucocytic inclusion bodies, fur­
ther study revealed the fact that they are present in practically 
all febrile conditions, in chronic pyogenic infections without 
fever, in certain severe injuries, and occasionally in normal 
human beings. In all likelihood they result from nuclear degen­
eration not infrequently observed in septic states and have no 
specific bearing on the etiology of scarlatina. The evidence 
offered in favor of the protozoan origin of scarlet fever has never 
stood the test of close scrutiny. 
The belief that scarlet fever is due to an unknown virus, 
probably of filtrable character, is based largely upon the results 
of attempts to communicate the disease experimentally to ani­
mals. A number of observers have reported scarlatina-like mani­
festations in monkeys inoculated with infective material from 
active human cases of the disease. Among these observations the 
most interesting are those of Leva<liti, Landsteiner and Prasek,8 
who, by the inoculation of anthropoid apes, seem to have pro-
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duced what in all likelihood was true scarlatina. Exudate from 
the throats of individuals with scarlet fever was rubbed into the 
tonsils of apes and defibrinated blood injected subcutaneously, 
and in one instance material from a suppurating lymph gland. 
The animals, after an incubation period of about three days, are 
described as having a typical angina with characteristic exudate, 
enlargement of the follicles of the tongue, a generalized exanthem 
resembling that of scarlet fever, and in certain instances when 
the animals recovered desquamation of the skin. There was also 
present the characteristic lymphoid hyperplasia, and the histo­
logical lesions in the skin resembled those seen in scarlet fever. 
In al  the animals presenting such a picture S. hremolyticus was 
present, either in the blood or in the local lesions in the 
throat. Levaditi, Landsteiner and Prasek, however, did not 
think that streptococcus was accountable for the manifestations, 
inasmuch as when pure cultures of this organism were obtained 
from the infected animals or from human beings and inoculated 
into fresh apes, the phenomenon described could not be repro­
duced. They do not state that the organism of scarlet fever is a 
filtrable virus, but simply say that it is of unknown character­
istics. Cantacuzene 9 and. Bernhardt 10 claim to have induced a 
similar series of phenomena by the inoculation of monkeys of a 
lower order with human material. Levaditi, Landsteiner and 
Prasek failed to produc,e in a large series of lower monkeys the 
disease syndrome manifested by the apes, nor were subsequent 
investigators more successful in confirming the observations of 
Cantacuzene and of Bernhardt. From the failure to discover an 
organism of known characteristics, rather than from any posi­
tive evidence has grown the belief so generally held that the 
etiological agent of scarlatina is an ultramicroscopic virus. 
During the many years that investigators have searched for 
the causative agent of scarlet fever, and with the varying 
emphasis attached to  one or another species of parasite from 
time to time, the constant relationship to this disease of ·one 
organism, S. bremolyticus has become more and more significant. 
As early as 1885 Crook 11 reported the presence of streptococcus 
in the blood and organs of individuals dying of scarlet fever. 
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Loeffler,12 in addition, found this organism to be present in cer­
tain types of necrotic angina associated with scarlet fever and 
was furthermore successful in isolating the germ in pure culture. 
At this time Klein 13 lilrnwise isolated a streptococcus from the 
tissues of patients with scarlatina, which he named Streptococcus 
scarlatinre. In 1885 the latter observer, while investigating an 
outbreak of fever among certain cows belonging to a farm at 
Hendon, England, isolated from ulcerative lesions of the udders 
and from certain viscera, a streptococcus which he considered 
to be identical with Streptococcus scarlatinre. This observation 
was not only of great interest but also of very great importance, 
because the milk obtained from the infected cows was shown to 
have been consumed by persons who subsequently developed 
scarlet fever. 'l'hese early observations of the frequent relation­
ship of streptococcus to scarlatina were soon confirmed by many 
students of the disease in different parts of the world. In 1900 
Baginsky and Sommerfeld 14 reported the constant presence of 
streptococcus in the throat during the characteristic angina in 
seven hundred cases of scarlet fever. They also found this 
organism frequently in the blood, bone marrow and internal 
organs of patients dying of this disease. Other observers found 
streptococcus in the blood of fatal cases of scarlet fever in as 
many as 70 per cent. of the individuals studied. Hektoen,15 fur­
thermore, found the organism in the blood in 12 per cent. of 
patients during life, and his observations are of especial interest 
in that they indicate'that the usual bad prognostic import of this 
phenomenon does not necessarily hold for scarlet fever. 
In· addition to the presence of streptococcus in the throat and 
blood of individuals with scarlet fever, this organism has also 
been proven to be the m9st frequent cause of the septic com­
plication.'> of the disease. Many times in septic foci streptococcus 
has been found in pure culture, and it is an old observation that 
convalescent individuals with discharging suppurativ.e lesions 
are especially likely to give rise to return cases of scarlet fever, 
showing that in such lesions the causative virus persists in an 
active form for long periods of time. 
S.11-ch wideSP,read and COJ)Stant assoqiation of S .. hremolrticus
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with scarlet fever has led some investigators to propose the view 
that streptococcus is the etiological agent of this disease. Certain 
observers, on the other hand, oppose this belief and have con­
sidered it more likely that streptococcus plays in scarlatina the 
role of a secondary invader. The objections of this latter group 
to the etiological significance of streptococcus are based upon 
certain important considerations. As is well known, strepto­
coccus is an organism of very widespread distribution and gives 
rise to a variety of pathological lesions, such as abscess forma­
tion, cellulitis, septicremia and numerous other conditions. Fre­
quently the same individual may have throughout life repeated 
streptococcus infections, one attack not seeming to confer immu­
nity against subsequent invasion of the tissues by the same 
organism. The latter condition of affairs is especially true of 
erysipelas, one of the most characteristic of the streptococcus 
diseases. On the other hand, scarlet fever, in sharp contrast to 
other streptococcus infections, is a fairly definite clinical entity 
and one attack appears to give rise to an immunity of life-long 
duration. This peculiarity of scarlet fever might have been 
explained had it been possible to prove that the streptococcus 
associated with scarlet fever differed specifically from the hremo­
lytic streptococci causing the various septic processes. However, 
early cultural and biochemical studies have failed to demonstrate 
any significant differential characteristics by means of which 
Streptococcus scarlatinre could be separated biologically from 
similar streptococci found in other diseases. When grown in 
fluid or in solid media, hremolytic streptococci resemble one 
another very closely, whatever be their source. It is true that 
certain constant differences can be brought out by means of fer­
mentation of various carbohydrates, but such variations as exist 
apparently do not bear any specific relationship to a single dis­
ease process, and have been of but little aid in determining the 
etiological significance of streptococcus in scarlet fever. In 
addition to this object.ion, 'Jochmann 10 has emphasized especially 
his failure to find streptococcus in either blood or tissue of indi­
viduals dying in a few days from malignant forms of the disease. 
Since, therefore, types of streptococci indistinguishable from 
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those seen in scarlatina are found in a great v,ariety of disease 
conditions, and since the quality of the immunity in this disease 
differs widely in its duration from that observed in other strepto­
coccus infections, and finally because of J ochm.ann 's contention 
that streptococcus is not present in certain malignant types of 
scarlet fever, the conclusion has been drawn that streptococcus 
cannot be the cause of the disease. 
An effort to meet these objections has been made by the group 
of investigators who believe that streptococcus is the etiological 
agent of scarlet fever. The observation by Baginsky and Som­
merfeld of the constant presence of S. hremolyticus in the throats 
of all cases of scarlatina, an observation later confirmed by others, 
has done much to offset the inferences drawn from J ochmann 's 
failure to find it in a few instances of fulminant types, especially 
since we now know that the organism in the latter cases may have 
been localized in some inaccessible area. Attempts were made 
in addition to explain the immunity in scarlet fever and to estab­
lish the type specificity of the scarlatina! streptoco:ccus. Moser 17 
and Moser and Pirquet 18 have claimed that scarlatinal conva­
lescent serum agglutinates to a higher titer Streptococcus scarla­
time than does control serum from other diseases. Furthern'lore, 
they have prepared polyvalent serum from horses, using the 
streptococcus of scarlet fever as antigen and have studied the 
capacity of such sera to agglutinate specifically various strains 
of scarlatinal streptococci. The latter strains were agglutinated 
in dilutions of 1: 1000 or over, whereas hremolytic streptococci 
from other sources were not specifically agglutinated. As a con­
sequence of these observations Moser and Pirquet believed that 
the streptococcus of scarlet fever differs specifically from appar­
ently similar strains isolated from instances of erysipelas, 
phlegmon and puerperal sepsis. Meyer 10 and Rossiwall and 
Schick 20 have confirmed the results of Moser and Pirquet. Unfor­
tunately, however, certain later studies by Hasenknopf and 
Salge,21 Aronson,22 and Neufeld 23 failed to support the earlier
ones and grave doubt was thrown upon the specificity of Strepto­
coccus scarlatinre. 
Other interesting facts which indicate the specific relation-
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ship of streptococcus to scarlet fever have come from the studies 
of Gabritchewsky24 on the specific prophylaxis of scarlet fever 
by means of a vaccine prepared from S. scarlatinre, anµ of 
Moser 25 on the therapeusis of the disease by means of a specific 
antistreptococcus serum. Gabritchewsky and his co-workers 
immunized a large number of individuals against scarlet fever 
with a vaccine prepared from hremolytic streptococci isolated 
from scarlatina. During the process of immunization certain phe­
nomena occurred which were highly suggestive of the clinical 
manifestations of scarlet fever. In the majority of instances an 
area of erythema and swelling averaging 15 cm. in diameter 
developed at the site of the vaccine injection appearing in from 
eight to twenty-four hours and lasting about forty-eight hours. 
In general, the erythema was diminished or absent following a 
second injection some ten days later. In about 15 per cent. of 
the individuals inoculated a general reaction was observed. This 
general reaction consisted in fever of 1 ° C. or so, leucocytosis and 
an erythematous rash, having the characteristic distribution of 
the exanthem in scarlet fever. Some of those inoculated showed 
the typical ·angina and strawberry tongue peculiar to the disease 
and in a few instances signs of renal irritation were observed. 
In general individuals who were recovering from the disease or 
who had had it some years before failed to show either a local 
or general reaction. Administration of Moser's antiscarlatinal 
serum before the inoculation was shown to prevent the develop­
ment of both a local and a general reaction. Prophylactic 
immunization of this type seemed to diminish the incidence of 
scarlet fever among the inoculated. As a result of these observa­
tions Gabritchewsky and his assistants were strongly of the opin­
ion that streptococcus is the causative agent of scarlet fever. 
The therapeutic results obtained by the use of Moser's serum 
lent further support to this view. Moser immunized horses to 
hremolytic streptococci obtained from the blood of patients suf­
fering from scarlatina. The serum thus prepared was used 
therapeutically and is said to have had marked beneficial effects 
causing a drop in the temperature and pulse, a diminution of the 
toxremia, early disappearance of the rash and a marked short-
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ening of the duration of the disease. Escherich, who observed 
the work closely, was mnch impressed by the therapeutic value 
of the serum and likened its action to that of diphtheria anti­
toxin. Later antistreptococcic sera prepared by other investi­
gators, however, failed to display the therapeutic efficiency of 
l\foser's serum and created doubt in the minds of many concern­
ing the usefulness of such sera. 
Much other evidence both for and against the etiological rela­
tionship of streptococcus to scarlet fever was presented at this 
time and as one weighs its importance in retrospect, the positive 
seems of more significance than the negative. The outstanding 
objection, however, to the acceptance of streptococcus as the cause 
of scarlet fever remained the impossibility of differentiating 
satisfactorily this organism from hremolytic streptococci asso­
ciated with the great variety of septic conditions. As a result, 
other etiologic agents were searched for. Moser's serum dropped 
into disuse and streptococcus vaccine was no longer used in the 
prophylaxis of scarlet fever. Scientific opinion gradually came 
to hold that streptococcus bore an important but secondary rela­
tionship to scarlet fever, and tha.t the true cause must be sought 
among the unknown viruses. 
For many years confusion has existed and opinion has varied 
concerning the existence of biologically varying types of strepto­
coccus. Two diverging points of view developed, one maintain­
ing the unity of the species as a type, and the other holding that 
it comprised a group of organisms different from one another in 
their biological characteristics. Schottmiiller 26 in 1903 made an 
important contribution to the discussion in demonstrating 
between certain streptococci, differences based on their action 
on blood agar plates, one group hremolyzing the red blood 
cells and the other either failing to hremolyze or forming methem­
oglobin. This significant differentiation resulted in the 
establishment of the types now generally recognized as hremo­
lytic and nonhremolytic or green pigment producing strains. 
Further classification was attempted by numerous investigators 
who used as a basis of differentiation certain biochemical reac­
tions. Holman 27 in 1916, using carbohydrate fermentation as a 
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test, was able to demonstrate the existence of a number of sep­
arate fermentation types. Numerous efforts were also made to 
establish biological differences, especially among the hremolytic 
streptococci, by means of serological reaction methods which 
had proven singularly successful when employed for studying 
the various types of pneumococcus and meningococcus. As a 
result of these studies conflicting beliefs arose, and a definite 
opinion could not be giYen as to whether or not separate bio­
logical types of S. hremolyticus exist. As late as 1918 Swift and 
Kinsella, 28 using the complement :fi.--i::ation reaction as a test, made 
a series of observations of twenty-eight strains of hremolytic 
streptococcus from various sources. They found that they were 
unable to determine significant serological differences between 
the strains studied and are of the opinion that a striking homo­
geneity exists. Efforts to correlate such different types of hremo­
lytic streptococcus as had been determined with specific 
pathological lesions were also of indeterminable significance, 
varying types being found in association with the same disease. 
In 1918 Dochez, A very, and Lancefield 20 undertook a bio­
logical study of a great number of strains of S. hremolyticus, 
obtained from a variety of pathological conditions among the 
changing population of a large military establishment. The pur­
pose of this investigation was to determine if there exist among 
the hremolytic streptococci diverse biological types, as is the case 
in the instances of pneumococcus and meningococcus. The spe­
cific test reactions were those of agglutination and protection. 
Spontaneous non-specific flocculation, the most confusing factor 
in previous studies of specific agglutination of streptococcus, was 
avoided by the employment of special methods. The outcome 
of these studies was to prove that there are separate biological 
types among hremolytic streptococci, just as there are among 
other apparently closely related groups of microorganisms. More 
than 68 per cent. of the strains investigated comprised six easily 
distinguishable serological types. 
This study was part of a general investigation of the biology 
of streptococcus, and, as a result of the facts developed, Bliss and 
Dochez 30 undertook a reinvestigation of the much debated ques-
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tion of the unity of type of the S. hremolyticus so constantly 
associated with scarlet fever. An effort was made to answer 
J ochmann 's main objection to the etiological relationship of S. 
hremolyticus to scarlet fever, namely, that the organism is not 
present in every instance of the disease, and that it cannot be 
satisfactorily differentiated from hremolytic streptococci asso­
ciated with the common septic conditions. Bliss 81 found when 
cultures are made from the throat early in the course of scarlet 
fever that hremolytic streptococci are present in predominating 
numbers in 100 per cent. of individuals examined, thus con­
firming the earlier work of Baginsky and Sommerfeld. Immune 
sera were then prepared by the inoculation of rabbits with 
scarlet fever streptococci, and the capacity of these sera to agglu­
tinate specifically a large number of freshly isolated scarlet fever 
strains was tested. Ten such sera were prepared from different 
strains of scarlet fever streptococci and each serum was found 
to agglutinate more than 80 per cent. of the strains isolated from 
scarlatina! throats. Agglutinating sera prepared from strains 
of hremolytic streptococci derived from pathological sources 
other than scarlet fever in general, failed to agglutinate spe­
cifically the scarlatina! strains. Furthermore, strains of hremo­
lytic streptococci obtained from such conditions as tonsillitis, 
erysipelas, bronchopneumonia, and other septic diseases, as well 
as the various type streptococci, determined by Dochez, A very 
and Lancefield were not agglutinated by the scarlatina! anti­
streptococcic sera. The evidence in favor of the specificity of the 
agglutination reaction of scarlatina! streptococci was reinforced 
by r!)sults obtained from agglutinin absorption experiments. 
Scarlatina! streptococcic sera also afforded some protection of 
experimental animals against virulent scarlet fever streptococci, 
but had no protective power against hremolytic streptococci from 
other sources. This work indicates that the majority of hremo­
lytic streptococci found in association with scarlatina belong to 
a specific biological group and can, by appropriate methods, be 
distinguished from hmmolytic streptococci derived from other 
pathological conditions. These observations, I believe, confirm 
in a satisfactory manner the early studies of Moser and von Pir-
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quet on the same subject. Contemporaneously with Bliss, Tunni­
cliff 32 investigated, by means of the opsonic and agglutination 
reaction, a series of hremolytic streptococci isolated from patients 
during the early stages of scarlet fever. She concludes that the 
serum of sheep immunized with hremolytic streptococci from the 
throat in the acute stage of scarlet fever contains opsonins and 
agglutinins for the hremolytic streptococci that prevail in the 
throat and complicating lesions early in this disease, but not for 
bremolytic streptococci from other sources, such as erysipelas, 
mastoiditis, measles, influenza, diphtheria and the normal throat. 
The results of her absorption experiments also indicate that the 
hremolytic streptococcus from scarlet fever forms a distinct group, 
scarlatina! streptococci removing the opsonins and agglutinins 
for these cocci while absorption with a hremolytic streptococcus 
from erysipelas has no such effect. These results also suggest 
that the hremolytic streptococci from scarlet fever form a distinct 
serologic group. Somewhat later Gordon 33 found that eighteen 
strains of hremolytic streptococcus isolated from scarlatina were 
identical in their agglutinative reactions. None of these strains 
absorbed the agglutinins from immune sera prepared from cer­
tain other types of hremolytic streptococcus, designated by him 
as Types I and IL On the basis of this evidence, Gordon con­
cludes that the streptococci from the throat secretions in scarlet 
fever constitute a group immunologically distinct from other 
varieties of streptococcus pyogenes. Eagles 84 in a recent study 
compared the serological reactions of hremolytic streptococci 
from scarlet fever, puerperal sepsis, erysipelas and miscellaneous 
sources.- He confirms the immunological specificity of the scar­
latina! group and the clearness with which it can be separated 
from other types of streptococcus. He furthermore compared in 
an interesting manner a number of individual strains obtained 
at three to four day intervals from the same patient and demon­
strated a gradual but progressive loss of specific agglutinability, 
a phenomenon which we have observed, and of which I shall 
say more later. Williams 86 has also studied the serological reac­
tions of the scarlatina! streptococci and finds only 35 per cent. 
to belong to a single type, and is of the opinion that a greater 
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variability exists than is suggested by the work of the previous 
observers. Dick and Dick 36 have shown two strains of scarlet 
fever streptococci, one a mannite fermenter, and the other a 
non-ma.nnite fermenter, to be serologically distinct, and believe 
that the agglutination reaction is of but little importance in 
determining the character of the scarlatinal streptococci. 
It would seem, therefore, that the old question stressed by 
,T ochmann, concerning the specificity of the streptococcus of scar­
let fever still remains in dispute. The preponderance of evi­
dence, however, strongly favors the belief that these cocci 
comprise a separate biological group and that the best method 
for determining this specificity of type is by agglutination. In 
order that satisfactory results may be obtained from this reac­
tion certain rigid conditions must be complied with; spontaneous 
auto-agglutination must be prevented, and the streptococci in 
question must be studied fresh from their human environment. 
This latter requirement is of great significance. Recent studies 
by A very and Heidelberger 87 have shown that the type specificity 
of pneumococcus is dependent upon the chemical constitution 
of the capsular substance. The production of this substance is 
a variable function of the organism; it is greatest in its strictly 
parasitic phase and is reduced by all factors which reduce viru­
lence and lessen pathogenicity. That a similar loss of a specific 
function by scarlatina.I streptococci takes place when they are 
removed from their parasitic environment is extremely likely. 
Bliss and Stevens and Dochez 88 have emphasized the rapidity 
with which specific agglutinating qualities are lost upon con­
tinued growth of these streptococci in artificial medium and 
Eagles suggests that the same change may take place under the 
influence of the immune bodies formed by a scarlatina.I subject 
during convalescence. The suppression of specificity of serolog­
ical reaction under the influence of immune bodies is, of course, a 
well recognized and established phenomenon among the pneumo­
cocci. The results obtained, therefore, indicate that if a large 
number of strains of scarlatina.I streptococci are studied under 
appropriate conditions and within a short period of time from 
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their isolation during the acute stage of scarlet fever a high 
degree of serological specificity can be demonstrated. 
Streptococcus scarlatinre is found not only in the throats and 
organs of individuals suffering from anginal types of scarlet feveT 
but has also been obtained from atypical forms of the disease, 
healthy carriers and contaminated food products. Serologically 
specific streptococci have been isolated from the local lesions in 
scarlet fever arising from the infection of wounds and burns, 
from the throat in scarlet fever without a rash, and from the 
lochial discharge in instances of puerperal scarlet fever. Bliss 
succeeded in tracing a small outbreak of scarlatina in an isolated 
children's institution to a recently admitted healthy carrier of 
Streptococcus scarlatinm. Stevens and myself identified by 
means of agglutination and absorption reactions as scarlatina! 
streptococci organisms isolated both from the contaminated milk 
which had given rise to a milk-borne epidemic of scarlet fever, 
and from the throats of patients who contracted the disease from 
this milk. As a result of these studies the importance of J och­
mann 's objections to Streptococcus scarlatinre as the etiological 
agent of scarlet fever was much lessened and students again 
began to take an active interest in this organism as the probable 
cause of the disease. 
From the very beginning of the study of scarlet fever efforts 
have been made to produce the disease experimentally in animals 
and in man by inoculation with scarlatina! material. Most of 
these attempts have had in view the demonstration of an unknown 
virus of the filter passing type. Streptococcus scarlatinro, in spite 
of the presumptive evidence in its favor and of the fact that some 
of the most typical examples of scarlet fever in animals have been 
associated with its presence bas been but little tested for its 
capacity to produce the disease experimentally. Class 39 in 1899 
reported the experimental production of this disease in swine 
by an organism designated hy him as Micrococcus scarlatinre. 
This was a gram negative coccus isolated from three hundred 
cases of scarlet fever and was, in all probability, a streptococcus. 
Krumwiede, Nicoll and Pratt 40 in 1914 observed an accidental 
infection of a laboratory worker, who sucked into her mouth a 
10 
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mixture of living streptococci containing Streptococcus scarla­
tinru. Three days later this individual developed a sore throat 
and subsequently experienced a typical attack of scarlet fever 
with all the usual phenomena. Because of the interest aroused 
by this observation, efforts were made to infect monkeys with 
the same streptococcus, but no instance of the disease was suc­
cessfully produced. 
In 1921 Dick and Dick 41 made a series of human inoculations 
with certain organisms obtained from the throats of individuals 
suffering from scarlet fever. Among the organisms utilized for 
this purpose was Streptococcus scarlatime. 'l'hough some of the 
volunteers experienced sore throats as a result of the treatment, 
no true instance of experimental scarlet fever resulted. In 1923 
the same workers 42 repeated their efforts to produce scarlet fever 
in human volunteers. In the second series of observations a 
hremolytic streptococcus obtained from the infected finger of a 
nurse suffering from wound scarlet fever was used for purposes 
of inoc,ulation. Five volunteers were inoculated by swabbing 
the tonsils and pha1·ynx with four-day-old cultures of the strep­
tococcus in question. Three of these individuals remained with­
out evidence of infection and one suffered from sore throat and 
fever without a rash. The fifth volunteer, however, who had 
been inoculated with the streptococcus after three weeks' growth 
in artificial medium experienced a typical but mild attack of 
scarlet fever, beginning forty-four hours after inoculation, and 
characterized by sore throat, general malaise, nausea, fever, leu­
cocytosis, a typical rash and albuminuria. Desquamation began 
on the hands and feet on the tenth day, and was complete by the 
end of the fourth week. Five volunteers inoculated with filtrates 
of the above-mentioned organism remained well and showed 
neither sore throat nor rash. Subsequent inoculation of four of 
these volunteers with living unfiltered cultures of the original 
streptococcus resulted in the experimental production of another 
instance of scarlet fever. These observations were confirmed 
later by the same investigators 43 by the experimental production 
of another instance of· scarlet fever in an individual proven 
susceptible by the nse of a skin test devised by them. 
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In 1920 Dochez and Bliss, while studying the biological reac­
tions of Streptococcus scarlatinre, observed in a dog infected 
subcutaneously with living organisms, the development of an 
intense general erythema followed later by desquamation. 
Attempts to reproduce this phenomenon in dogs resulted in fail­
ure. Stevens and Dochez later tried other animals, including 
monkeys, without success. Failure in these instances seemed to 
be due to our inability to induce a local infection because of the 
low virulence of the organism for the animals employed. Finally 
Dochez and Sherman 44 were successful in producing in guinea­
pigs and young swine a series of manifestations comprising some 
of the principal phenomena of scarlet fever. Successful local 
infection was achieved by injecting melted agar subcutaneously 
and infiltrating the mass with living culture of Streptococcus 
scarlatinre. Since it had become increasingly evident that scar­
latina has a certain resemblance to diphtheria, in that there is 
a local infection in the throat from which the specific toxic sub­
stance is distributed, we hoped that a similar absorption of toxic 
material would take place from the local area of infected agar. 
This proved to be the case and guinea-pigs and swine treated in 
the manner described developed an erythematous rash, fever, 
leucocytosis and progressive loss of weight. From eight to twelve 
days following infection the swine had general scaly desquama­
tion and the guinea-pigs slight general desquamation and com­
plete separation of the skin over the pads of the feet. This 
phenomenon could not be induced when hremolytic streptococci 
from sources other than scarlet fever were utilized. Some of the 
guinea-pigs died acutely from the toxic substances absorbed 
from the locally inf.ected area, and after death streptococci 
could not be demonstrated by culture either in the blood or 
serous cavities. 
The production of experimental scarlet fever in human beings 
and in animals by inoculation with Streptococcus scarlatinre 
had by this time made it increasingly likely that this organism is 
the causative agent of the disease. The evidence in favor of the 
absorption from the area of local infection of a toxic substance 
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which might be responsible for the clinical picture, had again 
brought into the foreground the analogy with diphtheria. 
Investigators of scarlet fever have for many years been 
impressed with the similarity of this disease to diphtheria. 
Berge, 46 as early as 1895, suggested that scarlatina is due to a 
local infection in the throat with streptococcus and that the gen­
eral symptoms of the disease are due, as in diphtheria, to the 
absorp.tion into the general circulation of soluble toxins formed 
by the infecting microorganism at the site of the local disease. 
Gabritchewsky and his co-workers, in their studies of scarlatini­
form manifestations which followed immunization of human 
beings against scarlet fever by means of vaccines of killed cul­
tures of streptococcus scarlatinre, attributed these reactions to 
the presence of a toxin in the vaccines. They drew attention to 
the absence of a vaccine erythema in individuals who gave a 
history of having had scarlet fever, and its failure to develop in 
patients during the period of convalescence from this disease. 
Much evidence in favor of the existence of a soluble circu­
lating poison in scarlet fever has also come from the study of 
the so-called Schultz-Charlton extinction phenomenon. In 1918 
Schultz and Charlton •0 discovered that if one injects into the 
skin of a scarlet-fever patient with a bright red rash 1 cc. of 
serum from a normal person, or from a patient convalescent 
from scarlet feyer, there appears after a time at the site of the 
injection a characteristic change. This change begins after about 
six hours and consists in a complete blanching of the rash over 
an area of from one-half inch to a few inches in diameter. In 
the affected area the swollen follicles, which are a feature of 
many rashes, disappear. Looked at from a distance, the margin 
of the defect in the rash is generally sharply defined. The color 
of the blanched area is that of normal skin and the duration of 
the typical phenomenon coincides on the whole with that of the 
rash itself. On the other hand, serum taken from scarlet-fever 
patients during the acute stage of the illness invariably gave 
negative results. Subsequent investigators abundantly corrobo­
rated the accuracy of the observation of Schultz and Charlton. 
As a result of these later studies it was established that the serum 
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of about sixty per cent. of normal ·adults possesses the capacity 
to blanch the rash in an active case of scarlet fever; that con­
valescent scarlatina! serum gives a positive rash extinction test 
in from 80 to 100 per cent. of instances; and that the serum dur­
ing the active stages of scarlet fever never manifests blanching 
power. The Schultz-Charlton reaction was first used as a diag­
nostic test of scarlet fever, and the capacity to extinguish the 
rash in scarlet fever was believed to be due to a normal property 
of human serum, which is temporarily lost during the acute 
stage of scarlet fever and regained during convalescence. 
In 1923 Mair 47 published a study of the Schultz-Charlton 
reaction in which he confirmed in general the observations of 
previous workers but gave the phenomenon a much more satis­
factory explanation. He had an opportunity of studying the 
blanching power of the serum of a child both before and after 
an attack of scarlet fever and showed that the serum before 
the attack gave a negative Schultz-Charlton test, but during 
convalescence acquired the capacity to extinguish an active rash. 
This disproved the previous belief that a positive reaction was 
due to some property of normal human serum which is lost dur­
ing the acute stages of scarlet fever. He also showed that the 
sera of young children who had not had scarlet fever give a 
negative reaction in a much greater proportion of instances than 
do adult sera and that the reactivity of the sera of new-born 
infants corresponds with that of the mothers. 
Mair had been interested for some years in the resemblance of 
scarlet fever to diphtheria. As a result of his later work, he 
came to believe that the rash and other changes in the skin in 
scarlet fever are due to a scarlatina! toxin which has entered 
into combination with the tissue cells. Among the affected cells 
are those contractile elements which have been shown to exist 
even in capillary blood-vessels, and to the function of which the 
normal tone of the capillaries is due. The toxin interferes with 
the function of these cells and a loss of tone of the capillaries 
results in the erythema and exudative phenomena with which we 
are familiar in the scarlatina! rash. He supposes that the serum 
giving a positive Schultz-Charlton reaction contains an antitoxin 
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which is able to dislodge and neutralize the toxin fixed in the 
cells, and thus restores their normal function over the area 
injected. He adds that the true causal organism when discov­
ered should be capable of producing a toxin, and that the immu­
nization of animals to this poison should give rise to an antito,xin 
capable of producing a positive Schultz-Charlton reaction 
in man. 
·we also had been pondering over the analogy between scarlet
fever and diphtheria and, at the time of the publicatoin of Mair's 
observations, had already produced in horses by immunization to 
Streptococcus scarlatina; an antitoxic serum of the type postu­
lated by him. Struck by the fact that occasionally in guinea­
pigs inoculated for the production of experimental scarlet fever 
sufficient poison was absorbed from the local lesion to kill the 
animals acutely, we determined to make use of the method for 
the production of an antitoxic serum in horses. Masses of melted 
nutrient agar were injected beneath the skin and then infiltrated 
with increasing doses of Streptococcus scarlatinre. The animals 
experienced a general reaction, and some of them, curiously 
enough, showed loss of hair and extensive general desquamation. 
After nine months' immunization the first animal was bled and 
his serum tested by Blake, 'frask and Lynch 48 for its corre­
spondence with human convalescent scarlatina! serum. When 
injected intracutaneously in a patient with a bright rash in the 
acute stage of scarlet fever this serum caused a complete extinc­
tion of the rash over an area five to ten centimetres in diameter. 
The blanching appeared in from six to twelve hours following 
injection of the serum and persisted throughout the course of the 
disease. As a rule, the characteristic pigmentation and desquam­
ation were absent during convalescence over the blanched area. 
Antisera prepared from other hremolytic streptococci and from 
Streptococcus scarlatinre injected intravenously into animals, 
failed to induce blanching of the rash. Furthermore, scarlatini­
form rashes in such conditions as erysipelas, measles, and other 
exanthematic diseases were not influenced by the intracutaneous 
injection of the scarlatinal antitoxin. Injection of a sufficient 
quantity of the serum intramuscularly in a patient in the exan-
F1a. !.-Blanching of skin in human scarlet fever due to intracutancous injection of scar­
lutinal strep. antitox. (Blake, Trask & Lynch.) 
F1G. 2.-Dcsquamation following experirncnta1 scarlet fever in guinea-pigs. 
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thematous stage of scarlet fever causes a complete fading of the 
rash over the whole body in from twelve to twenty-four hours. 
Blake and Trask 40 have demonstrated that there is present 
in the circulating blood and in the urine during the acute stage 
of scarlet fever a toxic substance which causes an erythematous 
reaction when injected intracutaneously in individuals whose 
blood serum gives a negative rash extinction test. This sub­
stance appears to be identical with the culture toxin of the Dicks 
and circulates in the blood for several days. When patients with 
scarlet fever having easily demonstrable amounts of this poison 
in the blood are injected with scarlatinal antitoxin, the circu­
lating toxin is rapidly neutralized, a single dose of forty cubic 
centimetres causing its complete disappearance throughout the 
remaining course of the disease. The antitoxin quickly pre­
dominates in the blood and the treated patients' serum acquires 
the capacity to induce a positive Schultz-Charlton extinction 
test, a property that does not develop in untreated patients 
until late convalescence. The other toxic manifestations of the 
diseases are likewise favorably influenced. An immune horse 
serum, therefore, prepared in the manner described, seems to 
contain a potent antitoxin and behaves in every way in a man­
ner similar to human convalescent scarlet fever serum. 
The further studies of Dick and Dick "0 demonstrating the 
presence of a toxic substance in filtrates from blood broth cul­
tures of Streptococcus scarlatinre have brought to light a number 
of new and important facts which develop still further the 
analogy between scarlet fever and diphtheria. The toxic filtrate 
was obtained by these authors from a strain of streptococcus with 
which they had produced experimental scarlet fever in man. 
When individuals who give a negative history for scarlet fever 
are injected intracutaneously with small amounts of this toxin, 
within about six hours there appears at the site of inoculation a 
small circular area of erythema, wh_ich increases in size and 
intensity of color for from eighteen to thirty-six hours. Fre­
quently the local reaction is accompanied by swelling of the 
skin. ·when a series of normal persons who have not had scarlet 
fever a.re injected with this su bstauce, 41.6 per cen,t. of t4cse 
15� HARVEY SOCIETY 
show a positive erythema reaction in the skin, a manifestation 
resembling the Schick test for susceptibility to diphtheria. The 
remainder who give a negative reaction are considered to be 
immune, because of the probable presence of circulating anti­
toxin in the blood, just as in the case of diphtheria. In addition, 
patients who are recovering from scarlet fever when tested intra­
cutaneously with this substance, give but a very faintly positive 
or uniformly negative skin reaction. • A similar condition of 
affairs is found to exist among those who have had scarlet 
fever at some earlier period of life. If individuals who have 
been proven susceptible to scarlet fever by means of the Dick 
test, are injected subcutaneously with larger amounts of the 
toxin, they exhibit certain of the toxic manifestations of the 
disease, such as nausea and vomiting, fever and an erythematous 
rash. Vi7hen toxic filtrate is mixed in v,,:tro with a small amount 
of convalescent scarlet fever serum, its capacity to produce a 
positive skin reaction is completely neutralized. Neutralization 
of the reaction was also obtained in vivo by the injection into 
susceptible human beings of larger quantities of convalescent 
serum. More recent studies of the Dicks 51 have shown that 
individuals who re.act positively in the skin can be immunized 
by repeated doses of the toxin, Ro that within a relatively short 
period of time the skin reaction becomes negative, and there 
is some evidence to support the belief that such individuals may 
he immune to the disease scarlet fever. 
Zingher,62 in an extensive study, has confirmed the observa­
tions of the Dicks and extended them somewhat. He has shown 
that the Dick reaction is positive in the early stages of scarlet 
fever in most instances, and that it becomes increasingly negative 
as the disease progresses through convalescence. He has, fur­
thermore, drawn a very close analogy between the data obtained 
from the Schick test in diphtheria and those obtained from the 
Dick test in scarlet fever. In general, susceptibility to the latter 
reaction is greater in childhood and diminishes in adult life. 
There is also an inherited resistance to the toxin in infants whose 
mothers exhibit a negative reaction. 
These studies, therefore, indicate that there is present in 
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sterile filtrates from cultures of Streptococcus scarlatinre a toxic 
substance which bears a specific relationship to scarlet fever. 
By means of this substance it is possible to detect susceptibility 
in persons who have not suffered from scarlet :fever, and further­
more to demonstrate the development of immunity in patients 
who are recovering from an attack of the disease. This work 
brings further strong support to the belief that Streptococcus 
scarlatime is the etiological agent of scarlet fever. 
In 1921 Di Cristina/3 in Italy, obtained from the blood of 
patients with scarlet fever an anrerobic Gram-positive diplo­
coccus. Other Italian inYestigators subsequently isolated a simi­
lar organism from the nasopharynx, bone marrow, spleen and· 
desquamating skin of children with scarlet fever. This organ­
ism, on further study, was found to show specific serological 
reactions with the serum of recovered cases of scarlatina. Inocu­
lation of children with living cultures of the organism is said to 
have produced an attenuated form of scarlet fever. Further­
more, prophylactic inoculation with killed cultures prevented the 
development of scarlet fever among a number of children exposed 
to the disease. Unfortunately, we are not in a position as yet to 
determine with any assurance the significance of this organism 
in scarlet fever, since an opportunity to study it bacteriologically 
has not been afforded. 
Have we now reached the end of man's long struggle to find 
the cause of this interesting and at times formidable and dan­
gerous disease 1 Personally, I think we have. Belief that scarlet 
fever may be caused by a protozoan parasite, or by one of the 
mysterious ultramicroscopic viruses, must, I think, be discarded 
in view of the fact that the evidence brought forward in sup­
port of the causative relationship of such types of microorgan­
isms to the disease is entirely unconvincing. On the other hand, 
can we say with certainty that scarlet fever is caused by a type 
of Streptococcus hmmolyticus 1 Certainly a chain of evidence 
in favor of this organism has been patiently and progressively 
forged which is as strong as that in many diseases whose etiology 
is now accepted without discussion. The constant association 
of this organism ·with the primary and secondary manifestations 
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of the disease, its specific character, its capacity to produce the 
experimental disease in man and in animals, the ability of 
human convalescent scarlet-fever serum to neutralize the toxic 
effects of this streptococcus, the capacity of an antistreptococcus 
horse serum antitoxic in nature to counteract the specific toxic 
manifestations of the disease in man, and finally the isolation 
from Berkefeld filtrates of this streptococcus of a toxic substance 
which bears a specific relationship to immunity in scarlet fever, 
leaves little room to doubt that Streptococcus scarlatinre is the 
principal and probably only etiological agent of scarlet fever. 
Let us, therefore, be optimistic and assume that a just reward 
has come to those many soldiers in the army of science, too 
numerous to be mentioned in so short an exposition, and that 
another disease has been added to those about which the essential 
specific facts are known. Let us also hope that the methods of 
prevention and treatment based on these facts may prove 
as successful as the promising character of the preliminary 
work suggests. 
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